Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Enterprise Value (2017 - 2026)

Celcuity's (CELC) quarterly Enterprise Value came in at -$717.3 million in Q4 2025, down 205.1% YoY from $682.5 million in Q4 2024, and down 57.66% on a QoQ basis from -$455.0 million in Q3 2025.

Analysis

Celcuity (CELC) Enterprise Value (2017 - 2026) Analysis & Trends

Celcuity (CELC) has 10 years of Enterprise Value data on file, last reported at -$717.3 million in Q4 2025.

  • Quarterly Enterprise Value fell 205.1% year-over-year to -$717.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$717.3 million (down 205.1% YoY) and the FY2025 annual result came in at -$717.3 million, down 205.1% from the prior year.
  • Enterprise Value slipped to -$717.3 million in Q4 2025, from -$455.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$35.0 million in Q1 2021 to a low of -$717.3 million in Q4 2025.
  • A 5-year average of -$187.4 million and a median of -$162.9 million in 2023 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2021 — Enterprise Value tumbled 623.06% — and 2025, when it jumped 40.51%.
  • Tracing CELC's Enterprise Value over 5 years: stood at -$84.3 million in 2021, then sank by 99.97% to -$168.6 million in 2022, then declined by 7.12% to -$180.6 million in 2023, then plunged by 30.19% to -$235.1 million in 2024, then sank by 205.1% to -$717.3 million in 2025.
  • The last three Enterprise Value figures came in at -$717.3 million (Q4 2025), -$455.0 million (Q3 2025), and -$168.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Celcuity 5.25 Bn 5.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.79 Bn
Dec 31, 2025 4.37 Bn
Sep 30, 2025 1.68 Bn
Jun 30, 2025 351.12 Mn
Mar 31, 2025 176.87 Mn
Dec 31, 2024 251.09 Mn
Sep 30, 2024 289.34 Mn
Jun 30, 2024 323.23 Mn
Mar 31, 2024 487.05 Mn
Dec 31, 2023 191.04 Mn
Sep 30, 2023 70.52 Mn
Jun 30, 2023 96.22 Mn
Mar 31, 2023 67.42 Mn
Dec 31, 2022 47.43 Mn
Sep 30, 2022 92.52 Mn
Jun 30, 2022 69.03 Mn
Mar 31, 2022 61.19 Mn
Dec 31, 2021 112.47 Mn
Sep 30, 2021 177.92 Mn
Jun 30, 2021 262.06 Mn